Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) - TA1/TA2

Department of Defense · DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA) · Solicitation · DARPA-PS-26-124

posted 27 May 2026 · closed 24 June 2026 · NAICS 541714 · PSC AC12 · 2 postings

Summary

The Department of Defense's DARPA is soliciting proposals for Phase 1 of the Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) program, which aims to develop a fieldable blood analog system that can replace stored whole blood in early trauma care without cold‑chain or donor logistics. The effort focuses on creating sequentially administered blood analog components, rugged delivery formats, point‑of‑care diagnostics, and clinical practice guidelines, with the goal of advancing these technologies to high technology readiness levels for eventual commercialization.

View the official notice ↗

Want to know why the government is buying what they buy? Subscribe to the OODA Daily Pulse

The OODA Daily Pulse Report provides a detailed summary of the top technology, cybersecurity and global risks of the day. Our analysts curate stories, articles and insights from hundreds of vetted sources to inform your decisions and our research team provides long form context on topics destined to be of importance. Delivered free to your inbox five days a week at 10:00am.